Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 993 of 1,261
  1. US 7772230

    Chroman compound, processes for its preparation, and its pharmaceutical use

    CHINA PHARMACEUTICAL UNIVERSITY · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted
  2. US 7771963

    Methods for determining efficacy of chemotherapeutic agents

    Precision Therapeutics, Inc. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted
  3. US 7771732

    Polymer network compositions and associated methods

    The Board of Regents of the University of Texas System · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted
  4. US 7772188

    Methods and compositions for the treatment of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted
  5. US 7772250

    Compounds

    Theravance, Inc. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted
  6. US 7772239

    Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted
  7. US 7772370

    Antifungal polypeptides

    The Regents of the University of California · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted
  8. US 7772434

    Crystalline form of a β2 adrenergic receptor agonist

    Theravance, Inc. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted
  9. US 7772192

    Compositions and methods for treatment of disease with acetylated disaccharides

    The Regents of the University of California · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted
  10. US 7772259

    1,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted
  11. US 7772387

    Oligonucleotides comprising a modified or non-natural nucleobase

    Alnylam Pharmaceuticals, Inc. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted
  12. US 7771715

    Recombinant vector expressing multiple costimulatory molecules and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted
  13. US 7771707

    Abuse-deterrent drug formulations

    Collegium Pharmaceutical, Inc. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted
  14. US 7772219

    Methods of hormonal treatment utilizing extended cycle contraceptive regimens

    TEVA WOMEN'S HEALTH, INC. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted
  15. US 2010197640

    NOVEL SULFAMOYL-PHENYL-UREIDO COMPOUNDS AND THEIR USE AS MEDICAMENT

    4SC AG [DE] · Granted Aug 5, 2010 · Expires Jul 31, 2030

    granted
  16. US 7767645

    SH2 domain binding inhibitors

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  17. US 7767686

    Method of using adenosine receptor blockers during tissue ablation

    Covidien LP · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  18. US 7767689

    Carboline derivatives useful in the treatment of cancer

    PTC THERAPEUTICS, INC. · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  19. US 7767303

    Cleaning article containing hydrophilic polymers

    ReGenesis Group · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  20. US 7767429

    Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

    HALOZYME, INC. · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  21. US 7767680

    Ion channel modulators and methods of use

    Vertex Pharmaceuticals Incorporated · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  22. US 7767665

    1,3-benzothiazinone derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  23. US 7767672

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  24. US 7767677

    Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.